High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab (Q49534241)
Jump to navigation
Jump to search
scientific article published on 20 December 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab |
scientific article published on 20 December 2017 |
Statements
1 reference
High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab (English)
1 reference
Halin Bao
1 reference
Tuya Bai
1 reference
Koji Takata
1 reference
Takehiko Yokobori
1 reference
Takashi Ohnaga
1 reference
Takeshi Hisada
1 reference
Toshitaka Maeno
1 reference
Pinjie Bao
1 reference
Tomonori Yoshida
1 reference
Yuji Kumakura
1 reference
Hiroaki Honjo
1 reference
Makoto Sakai
1 reference
Makoto Sohda
1 reference
Minoru Fukuchi
1 reference
Bolag Altan
1 reference
Tadashi Handa
1 reference
Munenori Ide
1 reference
Tatsuya Miyazaki
1 reference
Kyoichi Ogata
1 reference
Tetsunari Oyama
1 reference
Kimihiro Shimizu
1 reference
Akira Mogi
1 reference
Takayuki Asao
1 reference
Ken Shirabe
1 reference
Hiroyuki Kuwano
1 reference
Kyoichi Kaira
1 reference
20 December 2017
1 reference
1 reference
15
1 reference
3
1 reference
3061-3067
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference